We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.78%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$377B
AUM Growth
+$49.7B
Cap. Flow
+$31.3B
Cap. Flow %
8.3%
Top 10 Hldgs %
41.14%
Holding
5,593
New
785
Increased
2,954
Reduced
1,009
Closed
322

Sector Composition

Rank Sector Weight
1 Technology 19.52%
2 Financials 7.13%
3 Consumer Discretionary 6.46%
4 Healthcare 5.43%
5 Communication Services 5.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NHTC icon
5001
Natural Health Trends
NHTC
$14.8M
$107 ﹤0.01%
+18
New +$123
XTKG
5002
DELISTED
X3 Holdings Co., Ltd. Class A Ordinary Shares
XTKG
0
ACB
5003
Aurora Cannabis
ACB
$169M
$100 ﹤0.01%
17
-25,140
-100% -$149K
TMQ
5004
Trilogy Metals
TMQ
$504M
$97 ﹤0.01%
200
VCNX
5005
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$92 ﹤0.01%
+27
New +$152
BNGO icon
5006
Bionano Genomics
BNGO
$12.5M
$91 ﹤0.01%
3
BOLT icon
5007
Bolt Biotherapeutics
BOLT
$7.4M
$90 ﹤0.01%
7
SRS icon
5008
ProShares UltraShort Real Estate
SRS
$14.8M
$89 ﹤0.01%
2
EQ icon
5009
Equillium
EQ
$144M
$87 ﹤0.01%
+104
New +$87
VCLT icon
5010
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.81B
$81 ﹤0.01%
1
-86,754
-100% -$6.86M
VLD
5011
DELISTED
Velo3D, Inc.
VLD
$79 ﹤0.01%
109
-4,119
-97% -$9.06K
QNCX icon
5012
Quince Therapeutics
QNCX
$21.5M
$78 ﹤0.01%
1
FTCI icon
5013
FTC Solar
FTCI
$41.6M
$77 ﹤0.01%
11
-2,575
-100% -$9.28K
DYAI icon
5014
Dyadic International
DYAI
$38.6M
$75 ﹤0.01%
72
BODI icon
5015
The Beachbody Company
BODI
$71.8M
$74 ﹤0.01%
+13
New +$92
ACET icon
5016
Adicet Bio
ACET
$77.6M
$73 ﹤0.01%
3
-22
-88% -$492
VGZ icon
5017
Vista Gold
VGZ
$250M
$73 ﹤0.01%
94
BGXX
5018
DELISTED
Bright Green Corporation Common Stock
BGXX
$73 ﹤0.01%
1,857
-5,763
-76% -$1.33K
BPT
5019
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
$72 ﹤0.01%
67
SKM icon
5020
SK Telecom
SKM
$11.4B
$71 ﹤0.01%
3
-3,696
-100% -$83.7K
LPAAU
5021
DELISTED
Launch One Acquisition Corp Unit
LPAAU
$70 ﹤0.01%
+7
New +$70
XBAP icon
5022
Innovator US Equity Accelerated 9 Buffer ETF April
XBAP
$131M
$67 ﹤0.01%
+2
New +$65
UUP icon
5023
Invesco DB US Dollar Index Bullish Fund
UUP
$423M
$56 ﹤0.01%
2
BTAI icon
5024
BioXcel Therapeutics
BTAI
$24.8M
$54 ﹤0.01%
6
-3
-33% -$40
DOYU
5025
DouYu International Holdings
DOYU
$140M
$54 ﹤0.01%
+5
New +$73

Similar funds

Barclays's Q3 2024 Portfolio in Review

As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.

  • Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
  • Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
  • Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
  • Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
  • Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
  • Barclays opened 785 new positions and closed 322 in Q3 2024.
  • Barclays's portfolio value rose 15% quarter-over-quarter to $377B.

Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.